Cranswick Regulatory News (CWK)

29 November 2023

Cranswick plc ("Cranswick" or the "Company")

Listing of Ordinary Shares pursuant to Deferred Bonus Plan

Application has been made to the UK Listing Authority and the London Stock Exchange for a listing of 2,666 Ordinary Shares of 10 pence each to be admitted to the Official List (the "Shares"). These shares will rank pari passu with the existing issued Ordinary Shares of the Company and it is expected that trading in the shares will become effective on 1 December 2023.

The Shares are to be issued as a result of the exercise of nil-cost options (and related dividend equivalents) granted under the Cranswick 2018 Deferred Bonus Plan to Christopher Aldersley, a Director of the Company. The Board of Directors has agreed to the early exercise of the nil cost options (and dividend equivalents) in consideration for Christopher Aldersley undertaking to the Company to retain 1,388 ordinary shares of 10p each (representing the after-tax number of shares subject to the Deferred Bonus Plan) from his existing holding of shares in the Company for the balance of the two year deferral period relating to the nil-cost options granted under the Deferred Bonus Plan.

Following the issue, Cranswick will have 53,899,366 Ordinary shares in issue. There are no shares held in treasury. Therefore, the total number of Ordinary Shares with voting rights in the Company will be 53,899,366 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules

 For further information, please contact:

Steven Glover, Company Secretary 01482 275 000